A novel strategy for glioblastoma treatment combining alpha-cyano-4-hydroxycinnamic acid with cetuximab using nanotechnology-based delivery systems. [electronic resource]
Producer: 20210702Description: 594-609 p. digitalISSN:- 2190-3948
- Brain Neoplasms -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Cetuximab -- chemistry
- Chitosan -- chemistry
- Coumaric Acids -- chemistry
- Drug Combinations
- Drug Compounding
- Drug Synergism
- Glioblastoma -- drug therapy
- Humans
- Nanoparticles
- Particle Size
- Polylactic Acid-Polyglycolic Acid Copolymer -- chemistry
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.